151 related articles for article (PubMed ID: 35813967)
1. Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study.
Muntyanu A; Nechaev V; Pastukhova E; Logan J; Rahme E; Netchiporouk E; Zubarev A; Litvinov IV
Lancet Reg Health Eur; 2022 Sep; 20():100454. PubMed ID: 35813967
[TBL] [Abstract][Full Text] [Related]
2. Burden and geographic distribution of oral cavity and oropharyngeal cancers in the Russian Federation.
Muntyanu A; Nechaev V; Pastukhova E; Logan J; Rahme E; Zubarev A; Netchiporouk E; Litvinov IV
Front Oncol; 2023; 13():1197287. PubMed ID: 37601694
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
4. Geographic Variations in Cutaneous Melanoma Distribution in the Russian Federation.
Muntyanu A; Savin E; Ghazawi FM; Alakel A; Zubarev A; Litvinov IV
Dermatology; 2020; 236(6):500-507. PubMed ID: 32506063
[TBL] [Abstract][Full Text] [Related]
5. Non-Melanoma Skin Cancer Distribution in the Russian Federation.
Muntyanu A; Ghazawi FM; Nedjar H; Rahme E; Alakel A; Zubarev A; Netchiporouk E; Litvinov IV
Dermatology; 2021; 237(6):1007-1015. PubMed ID: 33361697
[TBL] [Abstract][Full Text] [Related]
6. Syphilis and other sexually transmitted infections in the Russian Federation.
Borisenko KK; Tichonova LI; Renton AM
Int J STD AIDS; 1999 Oct; 10(10):665-8. PubMed ID: 10582634
[TBL] [Abstract][Full Text] [Related]
7. The abortion and contraceptive behavior: results of the all-Russian Research.
Rostovskaya TK; Shabunova AA; Knyazkova EA; Afzali M
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2022 May; 30(3):415-422. PubMed ID: 35670396
[TBL] [Abstract][Full Text] [Related]
8. [Economic effectiveness of vaccination against papilloma virus in the Russian Federation].
Kostinov MP; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2012; (2):43-50. PubMed ID: 22693810
[TBL] [Abstract][Full Text] [Related]
9. Patterns and trends of HPV-related cancers other than cervix in South Africa from 1994-2013.
Chikandiwa A; Pisa PT; Sengayi M; Singh E; Delany-Moretlwe S
Cancer Epidemiol; 2019 Feb; 58():121-129. PubMed ID: 30557819
[TBL] [Abstract][Full Text] [Related]
10. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
11. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
12. [Analysis on cancer incidence and mortality attributed to human papillomavirus infection in China, 2016].
Yuan MW; Wang HH; Duan RF; Xu KP; Hu SY; Qiao YL; Zhang Y; Zhao F
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):702-708. PubMed ID: 35589576
[No Abstract] [Full Text] [Related]
13. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M
Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature.
Khorasanizadeh F; Hassanloo J; Khaksar N; Mohammad Taheri S; Marzaban M; H Rashidi B; Akbari Sari A; Zendehdel K
Gynecol Oncol; 2013 Feb; 128(2):277-81. PubMed ID: 23200918
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence and mortality in Chukotka, 1997-2010.
Dudarev AA; Chupakhin VS; Odland JØ
Int J Circumpolar Health; 2013; 72():20470. PubMed ID: 23518507
[TBL] [Abstract][Full Text] [Related]
16. [The first results of the analysis of the activity of the cancer service of the North-Western Federal district of the Russian Federation, conducted on the basis of the created population cancer register of the Federal district.].
Merabishvili VM; Belyaev AM
Adv Gerontol; 2020; 33(2):228-239. PubMed ID: 32593236
[TBL] [Abstract][Full Text] [Related]
17. [The morbidity and mortality of cervix cancer in The Russian Federation in 2007-2018].
Tatarinova TA
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Jul; 29(4):892-897. PubMed ID: 34486854
[TBL] [Abstract][Full Text] [Related]
18. Cancer attributable to human papillomavirus infection in China: Burden and trends.
Lu Y; Li P; Luo G; Liu D; Zou H
Cancer; 2020 Aug; 126(16):3719-3732. PubMed ID: 32484937
[TBL] [Abstract][Full Text] [Related]
19. Global trends in testicular cancer incidence and mortality.
Rosen A; Jayram G; Drazer M; Eggener SE
Eur Urol; 2011 Aug; 60(2):374-9. PubMed ID: 21612857
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
